Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Gonorrhea Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Published by Transparency Market Research Product code 912370
Published Content info 186 Pages
Delivery time: 1-2 business days
Price
Back to Top
Gonorrhea Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027
Published: September 9, 2019 Content info: 186 Pages
Description

Title:
Gonorrhea Therapeutics Market (Gonococcal Infection: Uncomplicated Gonococcal Infection, Gonococcal Arthritis, Gonococcal Meningitis, and Endocarditis; Treatment: Monotherapy and Dual Therapy; Route of Administration: Oral and Injectable; Gender: Women and Men; Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027.

Scope of the Study

[186 Pages Report] Transparency Market Research (TMR), in its latest business study, identifies significant growth opportunities present in the gonorrhea therapeutics market for the forecast period of 2019-2027. The comprehensive business study traces significant trends and recent developments encircling the gonorrhea therapeutics landscape. In addition, it provides intelligent industry insights into the gonorrhea therapeutics market by lending an incisive assessment of the key drivers, restraints, threats, and opportunities.

This comprehensive business study offers a detailed assessment of the demand and supply chain in the gonorrhea therapeutics market. This exclusive guide determines the macroeconomic as well as microeconomic parameters that help in comprehending the growth of the gonorrhea therapeutics market during the forecast period.

The gonorrhea therapeutics market size has been evaluated in terms of value (US$ Mn). Information included in this exhaustive research report can aid stakeholders in the gonorrhea therapeutics market in determining profitable growth opportunities for their business advancement.

This exclusive research report also uncovers an in-depth SWOT assessment of the leading, prominent, and emerging market players operating in the gonorrhea therapeutics market. This assessment will aid stakeholders gain an incisive perspective apropos of the growth of the gonorrhea therapeutics market.

This in-depth business guide assesses and includes Porter's Five Forces to provide key growth strategies present in the gonorrhea therapeutics market during the forecast period. This exclusive guide provides key information about the competition present in the gonorrhea therapeutics market by identifying key competitors. The exclusive report also includes key strategies, financials, and notable developments present in the gonorrhea therapeutics market during the forecast period of 2019-2027.

Key Questions Answered:

An exclusive business study published by Transparency Market Research (TMR) offers intelligent insights apropos of the growth of the gonorrhea therapeutics market, through which stakeholders operating in the market can gain an edge over their competitors. Authors of the report assess the gonorrhea therapeutics market, and provide data and numbers demonstrating the impact of the influential trends and key developments in the industry.

The global study addresses the key questions of stakeholders in the gonorrhea therapeutics market.

  • What are the recent developments and market shifts observed in the gonorrhea therapeutics market?
  • What are the key winning imperatives for leading and prominent players functioning in the gonorrhea therapeutics market?
  • What are the significant trends stimulating the growth of the gonorrhea therapeutics market?
  • Which distribution channel will draw significant sales in the gonorrhea therapeutics market?

Research Methodology

Research carried out by analysts at TMR includes a robust research approach that includes both, primary and secondary research. In order to carry out primary research, discussions were scheduled with distributors, industry experts, vendors, and key opinion leaders. This significantly helps in assessing the demand-supply gap in the gonorrhea therapeutics market.

For carrying out secondary research, company websites, marketing collaterals, press releases, industry associations, and statistics presented by government websites were referred to.

Segmentation

In order to present an incisive view of the gonorrhea therapeutics market, analysts and researchers of the report have segregated the gonorrhea therapeutics market based on the gonococcal infection, treatment, route of administration, gender, distribution channel, and region. This comprehensive business study also analyzes the incremental opportunity present in the gonorrhea therapeutics market during the forecast period.

Table of Contents

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Gonorrhea Therapeutics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Gonococcal Infection Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Gonorrhea Therapeutics Market Analysis and Forecast, 2017-2027
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

  • 5.1. Regulatory Scenario by Region/globally
  • 5.2. Reimbursement Scenario by Region/globally

6. Global Gonorrhea Therapeutics Market Analysis and Forecast, by Gonococcal Infection Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Gonorrhea Therapeutics Market Forecast, by Gonococcal Infection Type, 2017-2027
    • 6.3.1. Uncomplicated Gonococcal Infection
    • 6.3.2. Gonococcal Arthritis
    • 6.3.3. Gonococcal Meningitis and Endocarditis
  • 6.4. Global Gonorrhea Therapeutics Market Attractiveness, by Gonococcal Infection Type

7. Global Gonorrhea Therapeutics Market Analysis and Forecast, by Treatment

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Gonorrhea Therapeutics Market Forecast, by Treatment, 2017-2027
    • 7.3.1. Monotherapy
    • 7.3.2. Dual Therapy
  • 7.4. Global Gonorrhea Therapeutics Market Attractiveness, by Treatment

8. Global Gonorrhea Therapeutics Market Analysis and Forecast, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Global Gonorrhea Therapeutics Market Forecast, by Route of Administration, 2017-2027
    • 8.3.1. Oral
    • 8.3.2. Injectable
  • 8.4. Global Gonorrhea Therapeutics Market Attractiveness, by Route of Administration

9. Global Gonorrhea Therapeutics Market Analysis and Forecast, by Gender

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Global Gonorrhea Therapeutics Market Forecast, by Gender, 2017-2027
    • 9.3.1. Women
    • 9.3.2. Men
  • 9.4. Global Gonorrhea Therapeutics Market Attractiveness, by Gender

10. Global Gonorrhea Therapeutics Market Analysis and Forecast, by Distribution Channel

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Global Gonorrhea Therapeutics Market Forecast, by Distribution Channel, 2017-2027
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
    • 10.3.4. Others
  • 10.4. Global Gonorrhea Therapeutics Market Attractiveness, by Distribution Channel

11. Global Gonorrhea Therapeutics Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Global Gonorrhea Therapeutics Market Forecast, by Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Global Gonorrhea Therapeutics Market Attractiveness, by Region

12. North America Gonorrhea Therapeutics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. North America Gonorrhea Therapeutics Market Forecast, by Gonococcal Infection Type, 2017-2027
    • 12.2.1. Uncomplicated Gonococcal Infection
    • 12.2.2. Gonococcal Arthritis
    • 12.2.3. Gonococcal Meningitis and Endocarditis
  • 12.3. North America Gonorrhea Therapeutics Market Forecast, by Treatment, 2017-2027
    • 12.3.1. Monotherapy
    • 12.3.2. Dual Therapy
  • 12.4. North America Gonorrhea Therapeutics Market Forecast, by Route of Administration, 2017-2027
    • 12.4.1. Oral
    • 12.4.2. Injectable
  • 12.5. North America Gonorrhea Therapeutics Market Forecast, by Gender, 2017-2027
    • 12.5.1. Women
    • 12.5.2. Men
  • 12.6. North America Gonorrhea Therapeutics Market Forecast, by Distribution Channel, 2017-2027
    • 12.6.1. Hospital Pharmacies
    • 12.6.2. Retail Pharmacies
    • 12.6.3. Online Pharmacies
    • 12.6.4. Others
  • 12.7. North America Gonorrhea Therapeutics Market Forecast, by Country, 2017-2027
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. North America Gonorrhea Therapeutics Market Attractiveness Analysis
    • 12.8.1. By Gonococcal Infection Type
    • 12.8.2. By Treatment
    • 12.8.3. By Route of Administration
    • 12.8.4. By Gender
    • 12.8.5. By Distribution Channel
    • 12.8.6. By Country

13. Europe Gonorrhea Therapeutics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Europe Gonorrhea Therapeutics Market Forecast, by Gonococcal Infection Type, 2017-2027
    • 13.2.1. Uncomplicated Gonococcal Infection
    • 13.2.2. Gonococcal Arthritis
    • 13.2.3. Gonococcal Meningitis and Endocarditis
  • 13.3. Europe Gonorrhea Therapeutics Market Forecast, by Treatment, 2017-2027
    • 13.3.1. Monotherapy
    • 13.3.2. Dual Therapy
  • 13.4. Europe Gonorrhea Therapeutics Market Forecast, by Route of Administration, 2017-2027
    • 13.4.1. Oral
    • 13.4.2. Injectable
  • 13.5. Europe Gonorrhea Therapeutics Market Forecast, by Gender, 2017-2027
    • 13.5.1. Women
    • 13.5.2. Men
  • 13.6. Europe Gonorrhea Therapeutics Market Forecast, by Distribution Channel, 2017-2027
    • 13.6.1. Hospital Pharmacies
    • 13.6.2. Retail Pharmacies
    • 13.6.3. Online Pharmacies
    • 13.6.4. Others
  • 13.7. Europe Gonorrhea Therapeutics Market Forecast, by Country/Sub-region, 2017-2027
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Spain
    • 13.7.5. Italy
    • 13.7.6. Rest of Europe
  • 13.8. Europe Gonorrhea Therapeutics Market Attractiveness Analysis
    • 13.8.1. By Gonococcal Infection Type
    • 13.8.2. By Treatment
    • 13.8.3. By Route of Administration
    • 13.8.4. By Gender
    • 13.8.5. By Distribution Channel
    • 13.8.6. By Country

14. Asia Pacific Gonorrhea Therapeutics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Asia Pacific Gonorrhea Therapeutics Market Forecast, by Gonococcal Infection Type, 2017-2027
    • 14.2.1. Uncomplicated Gonococcal Infection
    • 14.2.2. Gonococcal Arthritis
    • 14.2.3. Gonococcal Meningitis and Endocarditis
  • 14.3. Asia Pacific Gonorrhea Therapeutics Market Forecast, by Treatment, 2017-2027
    • 14.3.1. Monotherapy
    • 14.3.2. Dual Therapy
  • 14.4. Asia Pacific Gonorrhea Therapeutics Market Forecast, by Route of Administration, 2017-2027
    • 14.4.1. Oral
    • 14.4.2. Injectable
  • 14.5. Asia Pacific Gonorrhea Therapeutics Market Forecast, by Gender, 2017-2027
    • 14.5.1. Women
    • 14.5.2. Men
  • 14.6. Asia Pacific Gonorrhea Therapeutics Market Forecast, by Distribution Channel, 2017-2027
    • 14.6.1. Hospital Pharmacies
    • 14.6.2. Retail Pharmacies
    • 14.6.3. Online Pharmacies
    • 14.6.4. Others
  • 14.7. Asia Pacific Gonorrhea Therapeutics Market Forecast, by Country/Sub-region, 2017-2027
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Asia Pacific Gonorrhea Therapeutics Market Attractiveness Analysis
    • 14.8.1. By Gonococcal Infection Type
    • 14.8.2. By Treatment
    • 14.8.3. By Route of Administration
    • 14.8.4. By Gender
    • 14.8.5. By Distribution Channel
    • 14.8.6. By Country/Sub-region

15. Latin America Gonorrhea Therapeutics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Latin America Gonorrhea Therapeutics Market Forecast, by Gonococcal Infection Type, 2017-2027
    • 15.2.1. Uncomplicated Gonococcal Infection
    • 15.2.2. Gonococcal Arthritis
    • 15.2.3. Gonococcal Meningitis and Endocarditis
  • 15.3. Latin America Gonorrhea Therapeutics Market Forecast, by Treatment, 2017-2027
    • 15.3.1. Monotherapy
    • 15.3.2. Dual Therapy
  • 15.4. Latin America Gonorrhea Therapeutics Market Forecast, by Route of Administration, 2017-2027
    • 15.4.1. Oral
    • 15.4.2. Injectable
  • 15.5. Latin America Gonorrhea Therapeutics Market Forecast, by Gender, 2017-2027
    • 15.5.1. Women
    • 15.5.2. Men
  • 15.6. Latin America Gonorrhea Therapeutics Market Forecast, by Distribution Channel, 2017-2027
    • 15.6.1. Hospital Pharmacies
    • 15.6.2. Retail Pharmacies
    • 15.6.3. Online Pharmacies
    • 15.6.4. Others
  • 15.7. Latin America Gonorrhea Therapeutics Market Forecast, by Country/Sub-region, 2017-2027
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Latin America Gonorrhea Therapeutics Market Attractiveness Analysis
    • 15.8.1. By Gonococcal Infection Type
    • 15.8.2. By Treatment
    • 15.8.3. By Route of Administration
    • 15.8.4. By Gender
    • 15.8.5. By Distribution Channel
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Gonorrhea Therapeutics Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Middle East & Africa Gonorrhea Therapeutics Market Forecast, by Gonococcal Infection Type, 2017-2027
    • 16.2.1. Uncomplicated Gonococcal Infection
    • 16.2.2. Gonococcal Arthritis
    • 16.2.3. Gonococcal Meningitis and Endocarditis
  • 16.3. Middle East & Africa Gonorrhea Therapeutics Market Forecast, by Treatment, 2017-2027
    • 16.3.1. . Monotherapy
    • 16.3.2. Dual Therapy
  • 16.4. Middle East & Africa Gonorrhea Therapeutics Market Forecast, by Route of Administration, 2017-2027
    • 16.4.1. Oral
    • 16.4.2. Injectable
  • 16.5. Middle East & Africa Gonorrhea Therapeutics Market Forecast, by Gender, 2017-2027
    • 16.5.1. Women
    • 16.5.2. Men
  • 16.6. Middle East & Africa Gonorrhea Therapeutics Market Forecast, by Distribution Channel, 2017-2027
    • 16.6.1. Hospital Pharmacies
    • 16.6.2. Retail Pharmacies
    • 16.6.3. Online Pharmacies
    • 16.6.4. Others
  • 16.7. Middle East & Africa Gonorrhea Therapeutics Market Forecast by Country/Sub-region, 2017-2027
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Israel
    • 16.7.4. Rest of Middle East & Africa
  • 16.8. Middle East & Africa Gonorrhea Therapeutics Market Attractiveness Analysis
    • 16.8.1. By Gonococcal Infection Type
    • 16.8.2. By Treatment
    • 16.8.3. By Route of Administration
    • 16.8.4. By Gender
    • 16.8.5. By Distribution Channel
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (by Tier and Size of companies)
  • 17.2. Market Share Analysis by Company (2018)
  • 17.3. Company Profiles
    • 17.3.1. GlaxoSmithKline plc.
      • 17.3.1.1 Company Overview (Headquarters, Business Segments, Employee Strength)
      • 17.3.1.2 Financial Overview
      • 17.3.1.3 SWOT Analysis
      • 17.3.1.4 Strategic Overview
    • 17.3.2. Merck & Co., Inc.
      • 17.3.2.1 Company Overview (Headquarters, Business Segments, Employee Strength)
      • 17.3.2.2 Financial Overview
      • 17.3.2.3 SWOT Analysis
      • 17.3.2.4 Strategic Overview
    • 17.3.3. Pfizer Inc.
      • 17.3.3.1 Company Overview (Headquarters, Business Segments, Employee Strength)
      • 17.3.3.2 Financial Overview
      • 17.3.3.3 SWOT Analysis
      • 17.3.3.4 Strategic Overview
    • 17.3.4. AstraZeneca
      • 17.3.4.1 Company Overview (Headquarters, Business Segments, Employee Strength)
      • 17.3.4.2 Financial Overview
      • 17.3.4.3 SWOT Analysis
      • 17.3.4.4 Strategic Overview
    • 17.3.5. Hologic, Inc.
      • 17.3.5.1 Company Overview (Headquarters, Business Segments, Employee Strength)
      • 17.3.5.2 Financial Overview
      • 17.3.5.3 SWOT Analysis
      • 17.3.5.4 Strategic Overview
    • 17.3.6. Danaher
      • 17.3.6.1 Company Overview (Headquarters, Business Segments, Employee Strength)
      • 17.3.6.2 Financial Overview
      • 17.3.6.3 SWOT Analysis
      • 17.3.6.4 Strategic Overview
    • 17.3.7. Abbott
      • 17.3.7.1 Company Overview (Headquarters, Business Segments, Employee Strength)
      • 17.3.7.2 Financial Overview
      • 17.3.7.3 SWOT Analysis
      • 17.3.7.4 Strategic Overview
    • 17.3.8. Becton Dickinson and Company
      • 17.3.8.1 Company Overview (Headquarters, Business Segments, Employee Strength)
      • 17.3.8.2 Financial Overview
      • 17.3.8.3 SWOT Analysis
      • 17.3.8.4 Strategic Overview
    • 17.3.9. F. Hoffmann-La Roche Ltd
      • 17.3.9.1 Company Overview (Headquarters, Business Segments, Employee Strength)
      • 17.3.9.2 Financial Overview
      • 17.3.9.3 SWOT Analysis
      • 17.3.9.4 Strategic Overview
    • 17.3.10. Other Prominent Key Players

Note: Financial details for companies that do not report this information in public domain might not be captured.

List of Tables

  • Table 1: Global Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gonococcal Infection, 2017-2027
  • Table 2: Global Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2017-2027
  • Table 3: Global Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 4: Global Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gender, 2017-2027
  • Table 5: Global Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 6: North America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gonococcal Infection, 2017-2027
  • Table 7: North America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2017-2027
  • Table 8: North America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 9: North America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gender, 2017-2027
  • Table 10: North America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 11: Europe Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gonococcal Infection, 2017-2027
  • Table 12: Europe Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2017-2027
  • Table 13: Europe Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 14: Europe Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gender, 2017-2027
  • Table 15: Europe Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 16: Asia Pacific Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gonococcal Infection, 2017-2027
  • Table 17: Asia Pacific Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2017-2027
  • Table 18: Asia Pacific Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 19: Asia Pacific Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gender, 2017-2027
  • Table 20: Asia Pacific Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 21: Latin America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gonococcal Infection, 2017-2027
  • Table 22: Latin America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2017-2027
  • Table 23: Latin America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 24: Latin America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gender, 2017-2027
  • Table 25: Latin America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 26: Middle East & Africa Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gonococcal Infection, 2017-2027
  • Table 27: Middle East & Africa Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2017-2027
  • Table 28: Middle East & Africa Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2027
  • Table 29: Middle East & Africa Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Gender, 2017-2027
  • Table 30: Middle East & Africa Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027

List of Figures

  • Figure 1: Market Size, by Test Type (US$ Mn), 2018
  • Figure 2: Market Share, Top Trends, by Product Type
  • Figure 3: Global Gonorrhea Therapeutics Market Size (US$ Mn) and Forecast, 2018-2027
  • Figure 4: Global Gonorrhea Therapeutics Market Value Share, by Gonococcal Infection (2018)
  • Figure 5: Global Gonorrhea Therapeutics Market Value Share, by Treatment (2018)
  • Figure 6: Global Gonorrhea Therapeutics Market Value Share, by Route of Administration (2018)
  • Figure 7: Global Gonorrhea Therapeutics Market Value Share, by Gender (2018)
  • Figure 8: Global Gonorrhea Therapeutics Market Value Share, by Distribution Channel (2018)
  • Figure 9: Global Gonorrhea Therapeutics Market Value Share Analysis, by Gonococcal Infection, 2018 and 2027
  • Figure 10: Global Gonorrhea Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), by Uncomplicated Gonococcal Infection, 2017-2027
  • Figure 11: Global Gonorrhea Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), by Gonococcal Arthritis, 2017-2027
  • Figure 12: Global Gonorrhea Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), by Gonococcal Meningitis and Endocarditis, 2017-2027
  • Figure 13: Global Gonorrhea Therapeutics Market Attractiveness Analysis, by Gonococcal Infection, 2019-2027
  • Figure 14: Global Gonorrhea Therapeutics Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 15: Global Gonorrhea Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), by Monotherapy, 2017-2027
  • Figure 16: Global Gonorrhea Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), by Dual Therapy, 2017-2027
  • Figure 17: Global Gonorrhea Therapeutics Market Attractiveness Analysis, by Treatment, 2019-2027
  • Figure 18: Global Gonorrhea Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 19: Global Gonorrhea Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), by Oral, 2017-2027
  • Figure 20: Global Gonorrhea Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), by Injectable 2017-2027
  • Figure 21: Global Gonorrhea Therapeutics Market Attractiveness Analysis, by Route of Administration, 2019-2027
  • Figure 22: Global Gonorrhea Therapeutics Market Value Share Analysis, by Gender, 2018 and 2027
  • Figure 23: Global Gonorrhea Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), by Women, 2017-2027
  • Figure 24: Global Gonorrhea Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), by Men 2017-2027
  • Figure 25: Global Gonorrhea Therapeutics Market Attractiveness Analysis, by Gender, 2019-2027
  • Figure 26: Global Gonorrhea Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 27: Global Gonorrhea Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017-2027
  • Figure 28: Global Gonorrhea Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017-2027
  • Figure 29: Global Gonorrhea Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2017-2027
  • Figure 30: Global Gonorrhea Therapeutics Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 31: Global Gonorrhea Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 32: Global Gonorrhea Therapeutics Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 33: Global Gonorrhea Therapeutics Market Attractiveness Analysis, by Region, 2019-2027
  • Figure 34: North America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 35: North America Gonorrhea Therapeutics Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 36: North America Gonorrhea Therapeutics Market Value Share Analysis, by Gonococcal Infection, 2018 and 2027
  • Figure 37: North America Gonorrhea Therapeutics Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 38: North America Gonorrhea Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 39: North America Gonorrhea Therapeutics Market Value Share Analysis, by Gender, 2018 and 2027
  • Figure 40: North America Gonorrhea Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 41: North America Gonorrhea Therapeutics Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 42: North America Gonorrhea Therapeutics Market Attractiveness Analysis, by Gonococcal Infection, 2018?2027
  • Figure 43: North America Gonorrhea Therapeutics Market Attractiveness Analysis, by Treatment, 2018?2027
  • Figure 44: North America Gonorrhea Therapeutics Market Attractiveness Analysis, by Route of Administration, 2018?2027
  • Figure 45: North America Gonorrhea Therapeutics Market Attractiveness Analysis, by Gender, 2018?2027
  • Figure 46: North America Gonorrhea Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2018?2027
  • Figure 47: Europe Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 48: Europe Gonorrhea Therapeutics Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 49: Europe Gonorrhea Therapeutics Market Value Share Analysis, by Gonococcal Infection, 2018 and 2027
  • Figure 50: Europe Gonorrhea Therapeutics Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 51: Europe Gonorrhea Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 52: Europe Gonorrhea Therapeutics Market Value Share Analysis, by Gender, 2018 and 2027
  • Figure 53: Europe Gonorrhea Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 54: Europe Gonorrhea Therapeutics Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 55: Europe Gonorrhea Therapeutics Market Attractiveness Analysis, by Gonococcal Infection, 2018?2027
  • Figure 56: Europe Gonorrhea Therapeutics Market Attractiveness Analysis, by Treatment, 2018?2027
  • Figure 57: Europe Gonorrhea Therapeutics Market Attractiveness Analysis, by Route of Administration, 2018?2027
  • Figure 58: Europe Gonorrhea Therapeutics Market Attractiveness Analysis, by Gender, 2018?2027
  • Figure 59: Europe Gonorrhea Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2018?2027
  • Figure 60: Asia Pacific Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 61: Asia Pacific Gonorrhea Therapeutics Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 62: Asia Pacific Gonorrhea Therapeutics Market Value Share Analysis, by Gonococcal Infection, 2018 and 2027
  • Figure 63: Asia Pacific Gonorrhea Therapeutics Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 64: Asia Pacific Gonorrhea Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 65: Asia Pacific Gonorrhea Therapeutics Market Value Share Analysis, by Gender, 2018 and 2027
  • Figure 66: Asia Pacific Gonorrhea Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 67: Asia Pacific Gonorrhea Therapeutics Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 68: Asia Pacific Gonorrhea Therapeutics Market Attractiveness Analysis, by Gonococcal Infection, 2018?2027
  • Figure 69: Asia Pacific Gonorrhea Therapeutics Market Attractiveness Analysis, by Treatment, 2018?2027
  • Figure 70: Asia Pacific Gonorrhea Therapeutics Market Attractiveness Analysis, by Route of Administration, 2018?2027
  • Figure 71: Asia Pacific Gonorrhea Therapeutics Market Attractiveness Analysis, by Gender, 2018?2027
  • Figure 72: Asia Pacific Gonorrhea Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2018?2027
  • Figure 73: Latin America Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 74: Latin America Gonorrhea Therapeutics Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 75: Latin America Gonorrhea Therapeutics Market Value Share Analysis, by Gonococcal Infection, 2018 and 2027
  • Figure 76: Latin America Gonorrhea Therapeutics Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 77: Latin America Gonorrhea Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 78: Latin America Gonorrhea Therapeutics Market Value Share Analysis, by Gender, 2018 and 2027
  • Figure 79: Latin America Gonorrhea Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 80: Latin America Gonorrhea Therapeutics Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 81: Latin America Gonorrhea Therapeutics Market Attractiveness Analysis, by Gonococcal Infection, 2018?2027
  • Figure 82: Latin America Gonorrhea Therapeutics Market Attractiveness Analysis, by Treatment, 2018?2027
  • Figure 83: Latin America Gonorrhea Therapeutics Market Attractiveness Analysis, by Route of Administration, 2018?2027
  • Figure 84: Latin America Gonorrhea Therapeutics Market Attractiveness Analysis, by Gender, 2018?2027
  • Figure 85: Latin America Gonorrhea Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2018?2027
  • Figure 86: Middle East & Africa Gonorrhea Therapeutics Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 87: Middle East & Africa Gonorrhea Therapeutics Market Attractiveness Analysis, by Country, 2018-2027
  • Figure 88: Middle East & Africa Gonorrhea Therapeutics Market Value Share Analysis, by Gonococcal Infection, 2018 and 2027
  • Figure 89: Middle East & Africa Gonorrhea Therapeutics Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 90: Middle East & Africa Gonorrhea Therapeutics Market Value Share Analysis, by Route of Administration, 2018 and 2027
  • Figure 91: Middle East & Africa Gonorrhea Therapeutics Market Value Share Analysis, by Gender, 2018 and 2027
  • Figure 92: Middle East & Africa Gonorrhea Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 93: Middle East & Africa Gonorrhea Therapeutics Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 94: Middle East & Africa Gonorrhea Therapeutics Market Attractiveness Analysis, by Gonococcal Infection, 2018?2027
  • Figure 95: Middle East & Africa Gonorrhea Therapeutics Market Attractiveness Analysis, by Treatment, 2018?2027
  • Figure 96: Middle East & Africa Gonorrhea Therapeutics Market Attractiveness Analysis, by Route of Administration, 2018?2027
  • Figure 97: Middle East & Africa Gonorrhea Therapeutics Market Attractiveness Analysis, by Gender, 2018?2027
  • Figure 98: Middle East & Africa Gonorrhea Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2018?2027
Back to Top